Less than a month after the FDA rejected MDMA for PTSD treatment, and days after the agency set a September meeting to ...

“While President-elect Trump’s alliances may raise the visibility of psychedelics in public health discussions, we are ...

The Multidisciplinary Association for Psychedelic Studies (MAPS) has put forward the first-ever application for 'psychedelic-assisted therapy' that could be approved early in 2024. The MDMA-based ...

Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD ...

This gathering came shortly after the FDA’s decision to decline Lykos Therapeutics' application for midomafetamine ...

Voters in Massachusetts have an opportunity to open the door to personal and therapeutic use of plant-based psychedelics.

including the Multidisciplinary Association for Psychedelic Studies, or MAPS, a nonprofit research and educational organization that studies psychedelics and marijuana for a drug to treat PTSD ...

This collaboration with the Multidisciplinary Association for Psychedelic Studies (MAPS), showcased KCSA’s ability to elevate groundbreaking events. Additionally, KCSA Vice President McKenna Mil ...

director of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies. Many opponents to Question 4 generally support legalizing or decriminalizing psychedelic substances to ...

The group has pitched Question 4 as a key way to address mental health issues among veterans and received $500,000, its ...

I have completed the 100-hr training with Multidisciplinary Association for Psychedelic Studies (MAPS) in MDMA-assisted therapy and am in the supervision phase of my certificate in Ketamine ...